404 related articles for article (PubMed ID: 24702784)
1. Amyloid aggregation and deposition of human islet amyloid polypeptide at membrane interfaces.
Sasahara K; Morigaki K; Shinya K
FEBS J; 2014 Jun; 281(11):2597-612. PubMed ID: 24702784
[TBL] [Abstract][Full Text] [Related]
2. Binding of islet amyloid polypeptide to supported lipid bilayers and amyloid aggregation at the membranes.
Sasahara K; Morigaki K; Okazaki T; Hamada D
Biochemistry; 2012 Sep; 51(35):6908-19. PubMed ID: 22876830
[TBL] [Abstract][Full Text] [Related]
3. Interaction of hIAPP with model raft membranes and pancreatic beta-cells: cytotoxicity of hIAPP oligomers.
Weise K; Radovan D; Gohlke A; Opitz N; Winter R
Chembiochem; 2010 Jun; 11(9):1280-90. PubMed ID: 20440729
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol modulates the interaction of the islet amyloid polypeptide with membranes.
Caillon L; Duma L; Lequin O; Khemtemourian L
Mol Membr Biol; 2014; 31(7-8):239-49. PubMed ID: 25495656
[TBL] [Abstract][Full Text] [Related]
5. Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus.
Caillon L; Hoffmann AR; Botz A; Khemtemourian L
J Diabetes Res; 2016; 2016():5639875. PubMed ID: 26636105
[TBL] [Abstract][Full Text] [Related]
6. Membrane-mediated amyloid deposition of human islet amyloid polypeptide.
Sasahara K
Biophys Rev; 2018 Apr; 10(2):453-462. PubMed ID: 29204886
[TBL] [Abstract][Full Text] [Related]
7. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.
Westwell-Roper C; Dai DL; Soukhatcheva G; Potter KJ; van Rooijen N; Ehses JA; Verchere CB
J Immunol; 2011 Sep; 187(5):2755-65. PubMed ID: 21813778
[TBL] [Abstract][Full Text] [Related]
8. Islet amyloid polypeptide: aggregation and fibrillogenesis in vitro and its inhibition.
Seeliger J; Winter R
Subcell Biochem; 2012; 65():185-209. PubMed ID: 23225004
[TBL] [Abstract][Full Text] [Related]
9. Islet amyloid polypeptide inserts into phospholipid monolayers as monomer.
Engel MF; Yigittop H; Elgersma RC; Rijkers DT; Liskamp RM; de Kruijff B; Höppener JW; Antoinette Killian J
J Mol Biol; 2006 Feb; 356(3):783-9. PubMed ID: 16403520
[TBL] [Abstract][Full Text] [Related]
10. Human IAPP amyloidogenic properties and pancreatic β-cell death.
Fernández MS
Cell Calcium; 2014 Nov; 56(5):416-27. PubMed ID: 25224501
[TBL] [Abstract][Full Text] [Related]
11. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.
Sellin D; Yan LM; Kapurniotu A; Winter R
Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100
[TBL] [Abstract][Full Text] [Related]
12. Membrane Interactions of hIAPP Monomer and Oligomer with Lipid Membranes by Molecular Dynamics Simulations.
Zhang M; Ren B; Liu Y; Liang G; Sun Y; Xu L; Zheng J
ACS Chem Neurosci; 2017 Aug; 8(8):1789-1800. PubMed ID: 28585804
[TBL] [Abstract][Full Text] [Related]
13. Structural polymorphism of human islet amyloid polypeptide (hIAPP) oligomers highlights the importance of interfacial residue interactions.
Zhao J; Yu X; Liang G; Zheng J
Biomacromolecules; 2011 Jan; 12(1):210-20. PubMed ID: 21158384
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal fragment of human islet amyloid polypeptide is non-fibrillogenic in the presence of membranes and does not cause leakage of bilayers of physiologically relevant lipid composition.
Khemtémourian L; Engel MF; Liskamp RM; Höppener JW; Killian JA
Biochim Biophys Acta; 2010 Sep; 1798(9):1805-11. PubMed ID: 20570648
[TBL] [Abstract][Full Text] [Related]
15. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM
Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246
[TBL] [Abstract][Full Text] [Related]
16. Interplay between human islet amyloid polypeptide aggregates and micro-heterogeneous membranes.
Tan Q; Liu H; Duan M; Huo S
Biochim Biophys Acta Biomembr; 2021 Nov; 1863(11):183691. PubMed ID: 34224702
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer.
Gurzov EN; Wang B; Pilkington EH; Chen P; Kakinen A; Stanley WJ; Litwak SA; Hanssen EG; Davis TP; Ding F; Ke PC
Small; 2016 Mar; 12(12):1615-26. PubMed ID: 26808649
[TBL] [Abstract][Full Text] [Related]
18. A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity.
Brender JR; Hartman K; Reid KR; Kennedy RT; Ramamoorthy A
Biochemistry; 2008 Dec; 47(48):12680-8. PubMed ID: 18989933
[TBL] [Abstract][Full Text] [Related]
19. Co-assembly of human islet amyloid polypeptide (hIAPP)/insulin.
Liu P; Zhang S; Chen MS; Liu Q; Wang C; Wang C; Li YM; Besenbacher F; Dong M
Chem Commun (Camb); 2012 Jan; 48(2):191-3. PubMed ID: 22003494
[TBL] [Abstract][Full Text] [Related]
20. The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets.
Meier DT; Entrup L; Templin AT; Hogan MF; Mellati M; Zraika S; Hull RL; Kahn SE
Diabetologia; 2016 Oct; 59(10):2166-71. PubMed ID: 27393137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
